Philosophy of Care
Dr. Parikh is an adult medical oncologist who specializes in medical treatment of genitourinary malignancies including kidney/renal cell, bladder, prostate, ureteral cancers /germ cell tumor cancers.
She is a strong advocate for providing patients with comprehensive care such as mutational profiling, regional therapies, clinical trials and supportive care.
Dr. Parikh is an adult medical oncologist who specializes in medical treatment of genitourinal cancers including kidney/renal cell, bladder, prostate, ureteral and testicular cancer/germ cell tumor.
Dr. Parikh is interested in conducting clinical trials for these malignancies and has a particular interest in novel treatments for prostate, renal, and bladder cancer including molecular targeted therapies, immunotherapies and therapies to overcome resistance.
Hematology and Oncology
M.D., UC Davis School of Medicine, Davis CA 2011
M.Sc., UC Irvine, Irvine CA 1997
B.S., Boston University, Boston MA 1995
UC Davis Medical Center, Sacramento CA 2011-2014
Oncology, UC Davis Medical Center, Sacramento CA 2014-2016
American Board of Internal Medicine, 2014
American Board of Internal Medicine, Hematology and Oncology, 2017
Honors and Awards
Joseph Sullivan Research Award, 2016
Senior Resident of the year, UC Davis Health, Internal Medicine, 2014
Academic Forum award for best clinical vignette UC Davis Health, Internal Medicine, 2013
Allan T. Nunn Memorial Scholarship, UCD School of Medicine - for interest in pursuit of cancer research/oncology, 2011
Select Recent Publications
Parikh, M, Riess, J, Lara, PN. New and emerging developments in extensive-stage small cell lung cancer therapeutics. Current opinion in oncology. 2016;28(2): 97-103.
Dumas A, Parikh M, DeMartini J. A lump in the elbow- where did all that calcium come from? Journal of Investigative Medicine. 2014;62(1): 251.
DeVita, RJ, Parikh, M, Jiang, J, Fair, JA, Young, JR, Walsh, TF, Goulet, MT, Lo, JL, Ren, N, Yudkovitz, JB, Cui, J, Yang, YT, Cheng, K, Rohrer, SP, Wyvratt, MJ. Identification of neutral 4-O-alkyl quinolone nonpeptide GnRH receptor antagonists. Bioorganic & medicinal chemistry letters. 2004;14(22): 5599-603.
Lin, P, Parikh, M, Lo, JL, Yang, YT, Cheng, K, Smith, RG, Fisher, MH, Wyvratt, MJ, Goulet, MT. Heterocyclic derivatives of 2-(3,5-dimethylphenyl)tryptamine as GnRH receptor antagonists. Bioorganic & medicinal chemistry letters. 2001;11(8): 1077-80.
DeVita, RJ, Walsh, TF, Young, JR, Jiang, J, Ujjainwalla, F, Toupence, RB, Parikh, M, Huang, SX, Fair, JA, Goulet, MT, Wyvratt, MJ, Lo, JL, Ren, N, Yudkovitz, JB, Yang, YT, Cheng, K, Cui, J, Mount, G, Rohrer, SP, Schaeffer, JM, Rhodes, L, Drisko, JE, McGowan, E, MacIntyre, DE, Vincent, S, Carlin, JR, Cameron, J, Smith, RG. A potent, nonpeptidyl 1H-quinolone antagonist for the gonadotropin-releasing hormone receptor. Journal of medicinal chemistry. 2001;44(6): 917-22.
Fan WH, Parikh M, Snyder JK. Inverse Electron Demand Diels-Alder Reactions of Indole. A New Route to Beta-Carbolines. Tetrahedron Letters. 1995;36(37)(Sep): 6591-6594.